Chengfeng Qiu

578 citations
24 papers · 416 indexed · h-index 11
Topics
Lipoproteins and Cardiovascular Health (6 papers)Cancer, Lipids, and Metabolism (3 papers)HIV/AIDS drug development and treatment (3 papers)

In The Last Decade

Chengfeng Qiu

21 papers receiving 411 citations

Peers

Chengfeng Qiu
Comparison fields: 5 of 91
  • Surgery 118
  • Molecular Biology 109
  • Infectious Diseases 51
  • Endocrinology, Diabetes and Metabolism 49
  • Cancer Research 42
Replace Usha Agrawal with:
Usha Agrawal India
Mohamed Egypt
Xiaomin Liu China
Alexandra Colquhoun United Kingdom
Jaqueline de Azevêdo Silva Brazil
Ciprian Tănăsescu Romania
Rajab Mardani Iran
Nour K. Younis Lebanon
William S. Bowen United States
Fangfang Lv China
Chengfeng Qiu relative to Usha Agrawal India Usha Agrawal's profile →
Citations per field
00.5×1.5×2.2×
Usha Agrawal · 1×
Citations per year

Countries citing papers authored by Chengfeng Qiu

Since Specialization
Citations

This map shows the geographic impact of Chengfeng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengfeng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengfeng Qiu more than expected).

Fields of papers citing papers by Chengfeng Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengfeng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengfeng Qiu. The network helps show where Chengfeng Qiu may publish in the future.

Co-authorship network of co-authors of Chengfeng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengfeng Qiu. A scholar is included among the top collaborators of Chengfeng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengfeng Qiu. Chengfeng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 8
3 1
4 1
5 0
6 2
7 0
8 7
9 47
10 9
11 3
12 12
13 29
14 10
15 26
16 35
17 67
18 73
19 16
20 2

About Chengfeng Qiu

Chengfeng Qiu is a scholar working on Molecular Medicine, Transplantation and Cancer Research, having authored 24 papers that have together received 416 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Cancer, Lipids, and Metabolism (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Drug Discovery (1 citation), Modeling and Simulation (20 citations) and Endocrinology, Diabetes and Metabolism (49 citations). Chengfeng Qiu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xiang Zhao, Zhen Zhang, Quan Zhou, Mats Hillert, Zhihua Shi, Ziwei Deng, Jun Zhu, Yong Zhang, Zhenhua Zhang and Ling Zhang. Their work appears in journals such as Scientific Reports, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026